{"id":23526,"date":"2014-05-23T13:13:14","date_gmt":"2014-05-23T17:13:14","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=23526"},"modified":"2014-05-23T13:13:14","modified_gmt":"2014-05-23T17:13:14","slug":"sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526","title":{"rendered":"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 05\/23\/2014 (wallstreetpr) \u2013 <b>Sarepta Therapeutics Inc (NASDAQ:SRPT)<\/b> looks forward to a busy year in 2015 when it expects several of its experimental drugs to get the commercialization approval. In preparing for a potential big demand for its drugs, the company is scaling up capacity.<\/p>\n<p style=\"text-align: justify;\">It announced entering a deal to acquire a manufacturing facility that stands on a 26-acre land in Massachusetts for $25 million. The quoted money includes cost of upgrading the facility. The drug maker did not disclose the exact location of the facility that it intends to convert into a manufacturing unit.<\/p>\n<p style=\"text-align: justify;\">The transaction to acquire the new manufacturing plant is expected to close sometime in July this year, and that is when the company might reveal the currently withheld details about the facility.<\/p>\n<p style=\"text-align: justify;\"><b>A rich product pipeline<\/b><\/p>\n<p style=\"text-align: justify;\">Sarepta Therapeutics Inc (NASDAQ:SRPT) has a rich product pipeline that mostly target treatment of Duchenne muscular dystrophy,\u00a0 muscle degeneration that is common in young men and boys. The company believes that its experimental drugs are able to address up to half of the Duchenne muscular dystrophy condition if approved by the regulator.<\/p>\n<p style=\"text-align: justify;\">The company\u2019s lead drug candidate for Duchenne muscular dystrophy is eteplirsen, a therapy that the U.S. Food and Drug Administration has of late, become positive about despite earlier skepticism.<\/p>\n<p style=\"text-align: justify;\">Sarepta Therapeutics has about eight drug candidates in the Duchenne muscular dystrophy treatment pipeline that it hopes will win regulatory approval and hence, the preparation ahead of time to enhance the capacity.<\/p>\n<p style=\"text-align: justify;\"><b>Financial performance <\/b><\/p>\n<p style=\"text-align: justify;\">Sarepta Therapeutics released its 1Q2014 financial results on May 8, during which the company posted a net loss of 75 cents per share, better than 80 cents per share that analysts estimated for the quarter. Its revenue soared to $6.09 million, ahead of the consensus estimate at $3.45 million. Revenue was up 36 percent over the previous year\u2019s figure.<\/p>\n<p style=\"text-align: justify;\">Sarepta Therapeutics Inc (NASDAQ:SRPT) to Cambridge from Seattle last year and it has a network of contract manufacturers across the U.S. with a notably small plant in Oregon.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/23\/2014 (wallstreetpr) \u2013 Sarepta Therapeutics Inc (NASDAQ:SRPT) looks forward to a busy year in 2015 when it expects several of its experimental drugs [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":23527,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[6051,6050],"stock_ticker":[],"class_list":["post-23526","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqsrpt","tag-sarepta-therapeutics-inc-nasdaqsrpt","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/23\/2014 (wallstreetpr) \u2013 Sarepta Therapeutics Inc (NASDAQ:SRPT) looks forward to a busy year in 2015 when it expects several of its experimental drugs [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-05-23T17:13:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts\",\"datePublished\":\"2014-05-23T17:13:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526\"},\"wordCount\":345,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg\",\"keywords\":[\"NASDAQ:SRPT\",\"Sarepta Therapeutics Inc (NASDAQ:SRPT)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526\",\"name\":\"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg\",\"datePublished\":\"2014-05-23T17:13:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg\",\"width\":1024,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526","og_locale":"en_US","og_type":"article","og_title":"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts - Wall Street PR","og_description":"Boston, MA 05\/23\/2014 (wallstreetpr) \u2013 Sarepta Therapeutics Inc (NASDAQ:SRPT) looks forward to a busy year in 2015 when it expects several of its experimental drugs [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-05-23T17:13:14+00:00","og_image":[{"width":1024,"height":400,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts","datePublished":"2014-05-23T17:13:14+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526"},"wordCount":345,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg","keywords":["NASDAQ:SRPT","Sarepta Therapeutics Inc (NASDAQ:SRPT)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526","url":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526","name":"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg","datePublished":"2014-05-23T17:13:14+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/05\/Sarepta-Therapeutics.jpg","width":1024,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/sarepta-therapeutics-inc-nasdaqsrpt-to-invest-25-million-in-new-facility-in-massachusetts-23526#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Sarepta Therapeutics Inc (NASDAQ:SRPT) To Invest $25 Million In New Facility In Massachusetts"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/23526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=23526"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/23526\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/23527"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=23526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=23526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=23526"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=23526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}